Top compounds associated with response to ELN


Feature Type Standardized
Nominal ANOVA
mRNA KIN001-236 GDSC1000 pan-cancer AAC 0.047 0.1
mRNA Gefitinib GDSC1000 pan-cancer AAC -0.046 0.2
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.2
mRNA GSK-1904529A GDSC1000 pan-cancer AAC -0.048 0.2
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.053 0.2
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.047 0.2
mRNA Cisplatin GDSC1000 pan-cancer AAC -0.048 0.2
mRNA CP466722 GDSC1000 pan-cancer AAC 0.041 0.2
mRNA SCH-79797 CTRPv2 pan-cancer AAC -0.049 0.2
mRNA phloretin CTRPv2 pan-cancer AAC -0.048 0.2
Download CSV